Polypharmacology profiles and phylogenetic analysis of three-finger toxins from mamba venom: Case of aminergic toxins
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Complex cocktails: the evolutionary novelty of venomsTrends in Ecology & Evolution, 2013
- Non-enzymatic proteins from snake venoms: A gold mine of pharmacological tools and drug leadsToxicon, 2013
- The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agentToxicon, 2012
- G protein-coupled receptors, an unexploited animal toxin targets: Exploration of green mamba venom for novel drug candidates active against adrenoceptorsToxicon, 2012
- Venoms as a platform for human drugs: translating toxins into therapeuticsExpert Opinion on Biological Therapy, 2011
- Trends in the exploitation of novel drug targetsNature Reviews Drug Discovery, 2011
- Selective targeting of G‐protein‐coupled receptor subtypes with venom peptidesActa Physiologica, 2011
- The Toxicogenomic Multiverse: Convergent Recruitment of Proteins Into Animal VenomsAnnual Review of Genomics and Human Genetics, 2009
- Therapeutic potential of venom peptidesNature Reviews Drug Discovery, 2003
- α-Latrotoxin and Its Receptors: Neurexins and CIRL/LatrophilinsAnnual Review of Neuroscience, 2001